论文部分内容阅读
wagemaker和Cade最近初步报告用血液透析法治疗6例精神分裂症,5例获显著好转。但是血液透析法有并发出血、感染和代谢紊乱的危险。为了弄清本疗法的确实疗效,作者向81个全血透析单位的医疗指导者发出质询书,要求提供该单位兼有肾功能衰竭和精神分裂症(经精神科医师确诊)的病人数。并对血液透析治疗前有精神分裂症的病例作出临床判断,有多少在透析治疗后好转、恶化或仍无变化。26个透析单位提供了53例病人。其中2例系在治疗中发生精神分裂症,1例是在因尿毒症作透析治疗
The wagemaker and Cade recently reported initial treatment of six cases of schizophrenia with hemodialysis, and five were significantly improved. But hemodialysis has the risk of concurrent blood, infection and metabolic disorders. To clarify the efficacy of this therapy, the author sent a medical questionnaire to 81 medical hemodialysis unit medical practitioners asking for the number of patients who had both renal failure and schizophrenia (diagnosed by a psychiatrist). And to make clinical judgments on the cases of schizophrenia before hemodialysis treatment, how much to improve after dialysis, to worsen or not to change. Twenty-six dialysis units provided 53 patients. Two of them were schizophrenic during treatment, and one was treated with dialysis due to uremia